| abstract |
The invention relates to a use of a culture medium containing: one or severa l mammalian plasma or sera; a chemical or biological compound having an antioxydative property and/or differentiating property, such as DMSO, retino ic acid, vitamin, for example vitamin E, or selenium; and/or one or several corticoids for the in vitro hepatitis C virus replication in primary mammali an hepatocytes. |